Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144 Topical Adminsitration for Skin Fibrosis in Patients With Systemic Sclerosis

NCT00781053 is registered in ClinicalTrials.gov with ISDIN as lead sponsor.

NCT NCT00781053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00781053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144 Topical Adminsitration for Skin Fibrosis in Patients With Systemic Sclerosis
Lead sponsor
ISDIN
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2010
Enrollment
38 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

skin fibrosis